New research from National Jewish Health suggests that long-acting beta-agonists (LABAs), commonly used in combination asthma ...
New research from National Jewish Health suggests that long-acting beta-agonists (LABAs), commonly used in combination asthma inhalers, are not ...
HealthDay on MSN
Long-acting β-agonist use not tied to increased severity of oral food challenge reactions
Reaction severity does not significantly differ between children with food allergy and asthma failing an oral food challenge (OFC) who are taking inhaled corticosteroid (ICS) alone or in combination ...
The findings provide further support of recommendations in the clinical guidelines to favor one therapy over the other. Patients with chronic obstructive pulmonary disease (COPD) being treated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results